Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -102.06 | N/A |
| PEG Ratio (TTM) | 1.34 | N/A |
| P/S Ratio (TTM) | 2.23 | N/A |
| P/B Ratio (TTM) | 2.12 | N/A |
| P/FCF Ratio (TTM) | 26.63 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.04% | N/A |
| ROE (TTM) | -2.11% | N/A |
| Net Profit Margin (TTM) | -2.07% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 71.12% | 88.20% | N/A |
| Revenue | 1.57% | 17.39% | N/A |
| Net Income | 67.91% | 85.77% | N/A |
| Cash Flow | 76.87% | 47.17% | N/A |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.60 | N/A |
| Quick Ratio (TTM) | 1.60 | N/A |
| D/E Ratio (TTM) | 0.76 | N/A |
| Interest Coverage (TTM) | 2.14 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 1.81 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |